Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: SnapDandCGMinType2Diabetes [NA]

View source ↗

Summary

A clinical trial is recruiting for a Type 2 diabetes mellitus study at Ramathibodi Hospital involving SnapD and CGMin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CGMin
  • SnapD

Snippet

Sponsor: Ramathibodi Hospital | Conditions: Type2 Diabetes Mellitus | NA | Status: RECRUITING